P18 SKIN EXPRESSION OF P16(INK4A), A BIOMARKER FOR CELLULAR SENESCENCE, DOES NOT PREDICT FRAILTY OR TREATMENT OUTCOME IN NEWLY DIAGNOSED MULTIPLE MYELOMA

por Smits, F., Groen, K., Stege, C., Seefat, M., Nijhof, I., van de Donk, N., Ypma, P., Zweegman, S.
Publicado 2023

P1462: POPULATION-BASED REAL WORLD RESULTS OF CD19-DIRECTED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: A DUTCH CAR T-CELL TUMORBOARD EXPERIE...

por Spanjaart, A. M., Pennings, E., Mutsaers, P., van Dorp, S., Jak, M., van Doesem, J., de Boer, J., Vermaat, J., Sijs-Szabo, A., van der Poel, M., Kuipers, I., Chamuleau, M., Nijhof, I., Minnema, M., Lugtenburg, P., van Meerten, T., Kersten, M. J.
Publicado 2022

P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE P...

por Groen, K., Stege, C., Nasserinejad, K., de Heer, K., van Kampen, R., Leys, R., Thielen, N., Westerman, M., Wu, K., Ludwig, I., Issa, D., Velders, G., Vekemans, M., van de Donk, N., Timmers, G., de Boer, F., Tick, L., van der Spek, E., de Waal, E., Sohne, M., Sonneveld, P., Nijhof, I., Klein, S., Levin, M., Ypma, P., Zweegman, S.
Publicado 2023

P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 14...

por Groen, K., Seefat, M., Nasserinejad, K., Stege, C. A., van der Spek, E., Bilgin, Y. M., Kentos, A., Sohne, M., van Kampen, R. J., Ludwig, I., Thielen, N., Durdu-Rayman, N., de Graauw, N. C., van de Donk, N. W., de Waal, E. G., Vekemans, M.-C., Timmers, G. J., van der Klift, M., Soechit, S., Geerts, P. A., Silbermann, M. H., Oosterveld, M., Nijhof, I., Sonneveld, P., Klein, S. K., Levin, M.-D., Zweegman, S.
Publicado 2022

P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV)

por Seefat, M.R., Stege, C.A.M., Timmers, G.J., Levin, M.D., Hoogendoorn, M., Ypma, P.F., Nijhof, I.S., Velders, G.A., Strobbe, L., Durdu-Rayman, N., Westerman, M., Davidis-van Schoonhoven, M.A., van Kampen, R.J.W., Beeker, A., Koster, A., Dijk, A.C., van de Donk, N.W.C.J., van der Spek, E., Leys, M.B.L., Silbermann, M.H., Groen, K., van der Burg-de Graauw, N.C.H.P., Sinnige, H.A.M., van der Hem, K.G., Levenga, T.H., Bilgin, Y.M., Sonneveld, P., Klein, S.K., Nasserinejad, K., Blommestein, H.M., Cucchi, D.G.J., Lissenberg-Witte, B.I., Zweegman, S.
Publicado 2023